<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-10-25" modified="2018-01-31" version="144">
<accession>O60331</accession>
<accession>B7Z9E7</accession>
<accession>C6GIJ7</accession>
<accession>C6GIJ8</accession>
<accession>Q7LE07</accession>
<name>PI51C_HUMAN</name>
<protein>
<recommendedName>
<fullName>Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma</fullName>
<shortName>PIP5K1-gamma</shortName>
<shortName>PtdIns(4)P-5-kinase 1 gamma</shortName>
<ecNumber>2.7.1.68</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Phosphatidylinositol 4-phosphate 5-kinase type I gamma</fullName>
<shortName>PIP5KIgamma</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">PIP5K1C</name>
<name type="synonym">KIAA0589</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2009" name="Biochem. J." volume="422" first="473" last="482">
<title>Two novel phosphatidylinositol-4-phosphate 5-kinase type Igamma splice variants expressed in human cells display distinctive cellular targeting.</title>
<authorList>
<person name="Schill N.J."/>
<person name="Anderson R.A."/>
</authorList>
<dbReference type="PubMed" id="19548880"/>
<dbReference type="DOI" id="10.1042/BJ20090638"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="1998" name="DNA Res." volume="5" first="31" last="39">
<title>Prediction of the coding sequences of unidentified human genes. IX. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.</title>
<authorList>
<person name="Nagase T."/>
<person name="Ishikawa K."/>
<person name="Miyajima N."/>
<person name="Tanaka A."/>
<person name="Kotani H."/>
<person name="Nomura N."/>
<person name="Ohara O."/>
</authorList>
<dbReference type="PubMed" id="9628581"/>
<dbReference type="DOI" id="10.1093/dnares/5.1.31"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Nature" volume="420" first="85" last="89">
<title>Recruitment and regulation of phosphatidylinositol phosphate kinase type 1 gamma by the FERM domain of talin.</title>
<authorList>
<person name="Di Paolo G."/>
<person name="Pellegrini L."/>
<person name="Letinic K."/>
<person name="Cestra G."/>
<person name="Zoncu R."/>
<person name="Voronov S."/>
<person name="Chang S."/>
<person name="Guo J."/>
<person name="Wenk M.R."/>
<person name="De Camilli P."/>
</authorList>
<dbReference type="PubMed" id="12422219"/>
<dbReference type="DOI" id="10.1038/nature01147"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TLN2</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2003" name="J. Cell Biol." volume="162" first="113" last="124">
<title>ARF6 stimulates clathrin/AP-2 recruitment to synaptic membranes by activating phosphatidylinositol phosphate kinase type Igamma.</title>
<authorList>
<person name="Krauss M."/>
<person name="Kinuta M."/>
<person name="Wenk M.R."/>
<person name="De Camilli P."/>
<person name="Takei K."/>
<person name="Haucke V."/>
</authorList>
<dbReference type="PubMed" id="12847086"/>
<dbReference type="DOI" id="10.1083/jcb.200301006"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ARF6</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="J. Cell Biol." volume="168" first="789" last="799">
<title>Regulation of the interaction between PIPKI gamma and talin by proline-directed protein kinases.</title>
<authorList>
<person name="Lee S.Y."/>
<person name="Voronov S."/>
<person name="Letinic K."/>
<person name="Nairn A.C."/>
<person name="Di Paolo G."/>
<person name="De Camilli P."/>
</authorList>
<dbReference type="PubMed" id="15738269"/>
<dbReference type="DOI" id="10.1083/jcb.200409028"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-649 AND SER-650</scope>
<scope>MUTAGENESIS OF SER-650</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="176" first="343" last="353">
<title>Type I gamma phosphatidylinositol phosphate kinase modulates adherens junction and E-cadherin trafficking via a direct interaction with mu 1B adaptin.</title>
<authorList>
<person name="Ling K."/>
<person name="Bairstow S.F."/>
<person name="Carbonara C."/>
<person name="Turbin D.A."/>
<person name="Huntsman D.G."/>
<person name="Anderson R.A."/>
</authorList>
<dbReference type="PubMed" id="17261850"/>
<dbReference type="DOI" id="10.1083/jcb.200606023"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH CDH1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2007" name="J. Cell Biol." volume="178" first="297" last="308">
<title>Type I gamma phosphatidylinositol phosphate kinase is required for EGF-stimulated directional cell migration.</title>
<authorList>
<person name="Sun Y."/>
<person name="Ling K."/>
<person name="Wagoner M.P."/>
<person name="Anderson R.A."/>
</authorList>
<dbReference type="PubMed" id="17635937"/>
<dbReference type="DOI" id="10.1083/jcb.200701078"/>
</citation>
<scope>FUNCTION IN CELL MIGRATION AND ADHESION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2010" name="PLoS ONE" volume="5" first="E11755" last="E11755">
<title>SIRT1 regulates thyroid-stimulating hormone release by enhancing PIP5Kgamma activity through deacetylation of specific lysine residues in mammals.</title>
<authorList>
<person name="Akieda-Asai S."/>
<person name="Zaima N."/>
<person name="Ikegami K."/>
<person name="Kahyo T."/>
<person name="Yao I."/>
<person name="Hatanaka T."/>
<person name="Iemura S."/>
<person name="Sugiyama R."/>
<person name="Yokozeki T."/>
<person name="Eishi Y."/>
<person name="Koike M."/>
<person name="Ikeda K."/>
<person name="Chiba T."/>
<person name="Yamaza H."/>
<person name="Shimokawa I."/>
<person name="Song S.Y."/>
<person name="Matsuno A."/>
<person name="Mizutani A."/>
<person name="Sawabe M."/>
<person name="Chao M.V."/>
<person name="Tanaka M."/>
<person name="Kanaho Y."/>
<person name="Natsume T."/>
<person name="Sugimura H."/>
<person name="Date Y."/>
<person name="McBurney M.W."/>
<person name="Guarente L."/>
<person name="Setou M."/>
</authorList>
<dbReference type="PubMed" id="20668706"/>
<dbReference type="DOI" id="10.1371/journal.pone.0011755"/>
</citation>
<scope>ACETYLATION AT LYS-265 AND LYS-268</scope>
<scope>DEACETYLATION BY SIRT1</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2009" name="J. Cell Sci." volume="122" first="3837" last="3850">
<title>PIP5K-driven PtdIns(4,5)P2 synthesis: regulation and cellular functions.</title>
<authorList>
<person name="van den Bout I."/>
<person name="Divecha N."/>
</authorList>
<dbReference type="PubMed" id="19889969"/>
<dbReference type="DOI" id="10.1242/jcs.056127"/>
</citation>
<scope>REVIEW ON FUNCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2015" name="EMBO J." volume="34" first="475" last="490">
<title>LAPTM4B is a PtdIns(4,5)P2 effector that regulates EGFR signaling, lysosomal sorting, and degradation.</title>
<authorList>
<person name="Tan X."/>
<person name="Sun Y."/>
<person name="Thapa N."/>
<person name="Liao Y."/>
<person name="Hedman A.C."/>
<person name="Anderson R.A."/>
</authorList>
<dbReference type="PubMed" id="25588945"/>
<dbReference type="DOI" id="10.15252/embj.201489425"/>
</citation>
<scope>INTERACTION WITH LAPTM4B</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2007" name="Am. J. Hum. Genet." volume="81" first="530" last="539">
<title>Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinositol pathway.</title>
<authorList>
<person name="Narkis G."/>
<person name="Ofir R."/>
<person name="Landau D."/>
<person name="Manor E."/>
<person name="Volokita M."/>
<person name="Hershkowitz R."/>
<person name="Elbedour K."/>
<person name="Birk O.S."/>
</authorList>
<dbReference type="PubMed" id="17701898"/>
<dbReference type="DOI" id="10.1086/520771"/>
</citation>
<scope>VARIANT LCCS3 ASN-253</scope>
<scope>CHARACTERIZATION OF VARIANT LCCS3 ASN-253</scope>
</reference>
<comment type="function">
<text evidence="6 7 9 10">Catalyzes the phosphorylation of phosphatidylinositol 4-phosphate (PtdIns4P) to form phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2). PtdIns(4,5)P2 is involved in a variety of cellular processes and is the substrate to form phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P3), another second messenger. The majority of PtdIns(4,5)P2 is thought to occur via type I phosphatidylinositol 4-phosphate 5-kinases given the abundance of PtdIns4P. Participates in a variety of cellular processes such as vesicle mediated transport, cell adhesion, cell polarization and cell migration. Together with PIP5K1A is required for phagocytosis, but they regulate different types of actin remodeling at sequential steps. Promotes particle attachment by generating the pool of PtdIns(4,5)P2 that induces controlled actin depolymerization to facilitate Fc-gamma-R clustering. Mediates RAC1-dependent reorganization of actin filaments. Required for synaptic vesicle transport. Controls the plasma membrane pool of PtdIns(4,5)P2 implicated in synaptic vesicle endocytosis and exocytosis. Plays a role in endocytosis mediated by clathrin and AP-2 (adaptor protein complex 2). Required for clathrin-coated pits assembly at the synapse. Participates in cell junction assembly. Modulates adherens junctions formation by facilitating CDH1 trafficking. Required for focal adhesion dynamics. Modulates the targeting of talins (TLN1 and TLN2) to the plasma membrane and their efficient assembly into focal adhesions. Regulates the interaction between talins (TLN1 and TLN2) and beta-integrins. Required for uropodium formation and retraction of the cell rear during directed migration. Has a role in growth factor- stimulated directional cell migration and adhesion. Required for talin assembly into nascent adhesions forming at the leading edge toward the direction of the growth factor. Negative regulator of T-cell activation and adhesion. Negatively regulates integrin alpha-L/beta-2 (LFA-1) polarization and adhesion induced by T-cell receptor. Together with PIP5K1A have a role during embryogenesis and together with PIP5K1B may have a role immediately after birth.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + 1-phosphatidyl-1D-myo-inositol 4-phosphate = ADP + 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="6">Activated by interaction with TLN2.</text>
</comment>
<comment type="subunit">
<text evidence="2 14">Interacts with TLN1 (By similarity). Interacts with TLN2; interaction stimulates lipid kinase activity. May compete with beta-integrins for the same binding site on TLN1 and TLN2. Interacts with ARF6. Interacts with AP2B1. Interacts with AP2M1; phosphorylation of PIP5K1C by CSK disrupts the interaction; clathrin competes with PIP5K1C (By similarity). Interacts with CDH1. Interacts with CSK (By similarity). Interacts with PLCG1; interaction is abolished upon EGF stimulation (By similarity). Interacts with LAPTM4B; promotes SNX5 association with LAPTM4B; kinase activity of PIP5K1C is required; interaction is regulated by phosphatidylinositol 4,5-bisphosphate generated by PIP5K1C (PubMed:25588945).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-8838062"/>
<interactant intactId="EBI-297509">
<id>P46940</id>
<label>IQGAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cell membrane</location>
<topology>Peripheral membrane protein</topology>
<orientation>Cytoplasmic side</orientation>
</subcellularLocation>
<subcellularLocation>
<location>Endomembrane system</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell junction</location>
<location>focal adhesion</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell junction</location>
<location>adherens junction</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell projection</location>
<location>ruffle membrane</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell projection</location>
<location>phagocytic cup</location>
</subcellularLocation>
<subcellularLocation>
<location>Cell projection</location>
<location>uropodium</location>
</subcellularLocation>
<text>Detected in plasma membrane invaginations. Isoform 3 is detected in intracellular vesicle-like structures.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>O60331-1</id>
<name>1</name>
<name>PIPKIgamma-90</name>
<name>PIPKIgamma-668</name>
<name>PIPkinIgamma-a</name>
<name>PIPKIgamma_i2</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>O60331-2</id>
<name>2</name>
<name>variant 700</name>
<name>PIPKIgamma-700</name>
<name>PIPKIgamma_i4</name>
<sequence type="described" ref="VSP_042078"/>
</isoform>
<isoform>
<id>O60331-3</id>
<name>3</name>
<name>variant 707</name>
<name>PIPKIgamma-707</name>
<name>PIPKIgamma_i5</name>
<sequence type="described" ref="VSP_042080"/>
</isoform>
<isoform>
<id>O60331-4</id>
<name>4</name>
<name>PIPKIgamma-87</name>
<name>PIPKIgamma-640</name>
<name>PIPkinIgamma-b</name>
<name>PIPKIgamma_i1</name>
<sequence type="described" ref="VSP_042079"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="12">Isoform 1 is strongly expressed in brain and also detected in heart and lung. Isoform 2 is strongly expressed in pancreas and liver and in lesser quantities in brain, heart, lung and kidney. Isoform 3 is detected in large amounts in heart and large intestine, is also present in lung, pancreas and thyroid, and to a lesser extent in brain, stomach and kidney.</text>
</comment>
<comment type="PTM">
<text evidence="2 8">Phosphorylation on Ser-650 negatively regulates binding to TLN2 and is strongly stimulated in mitosis. Phosphorylation on Tyr-649 is necessary for targeting to focal adhesions. Phosphorylation on Ser-650 and Tyr-649 are mutually exclusive. Phosphorylated by SYK and CSK (By similarity). Tyrosine phosphorylation is enhanced by PTK2 signaling. Phosphorylated at Tyr-639 upon EGF stimulation. Some studies suggest that phosphorylation on Tyr-649 enhances binding to tailins (TLN1 and TLN2). According to PubMed:15738269 phosphorylation at Tyr-649 does not directly enhance binding to tailins (TLN1 and TLN2) but may act indirectly by inhibiting phosphorylation at Ser-650.</text>
</comment>
<comment type="PTM">
<text evidence="13">Acetylation at Lys-265 and Lys-268 seems to decrease lipid kinase activity. Deacetylation of these sites by SIRT1 positively regulates the exocytosis of TSH-containing granules from pituitary cells.</text>
</comment>
<comment type="disease" evidence="11">
<disease id="DI-01893">
<name>Lethal congenital contracture syndrome 3</name>
<acronym>LCCS3</acronym>
<description>A form of lethal congenital contracture syndrome, an autosomal recessive disorder characterized by degeneration of anterior horn neurons, extreme skeletal muscle atrophy, and congenital non-progressive joint contractures (arthrogryposis). The contractures can involve the upper or lower limbs and/or the vertebral column, leading to various degrees of flexion or extension limitations evident at birth. LCCS3 patients present at birth with severe multiple joint contractures and severe muscle wasting and atrophy, mainly in the legs. Death occurs minutes to hours after birth due to respiratory insufficiency. The phenotype can be distinguished from that of LCCS1 by the absence of hydrops, fractures and multiple pterygia, and from LCCS2 by the absence of neurogenic bladder defect.</description>
<dbReference type="MIM" id="611369"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="sequence caution" evidence="17">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA25515" version="1"/>
</conflict>
<text>Translation N-terminally shortened.</text>
</comment>
<dbReference type="EC" id="2.7.1.68"/>
<dbReference type="EMBL" id="FJ965536">
<property type="protein sequence ID" value="ACS73483.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="FJ965537">
<property type="protein sequence ID" value="ACS73484.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB011161">
<property type="protein sequence ID" value="BAA25515.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK315912">
<property type="protein sequence ID" value="BAH14283.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC005542">
<property type="protein sequence ID" value="AAC32904.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC093071">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC004637">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS32872.1">
<molecule id="O60331-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS56074.1">
<molecule id="O60331-4"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74257.1">
<molecule id="O60331-3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001182662.1">
<molecule id="O60331-4"/>
<property type="nucleotide sequence ID" value="NM_001195733.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001287778.1">
<molecule id="O60331-3"/>
<property type="nucleotide sequence ID" value="NM_001300849.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_036530.1">
<molecule id="O60331-1"/>
<property type="nucleotide sequence ID" value="NM_012398.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.282177"/>
<dbReference type="PDB" id="2G35">
<property type="method" value="NMR"/>
<property type="chains" value="B=646-653"/>
</dbReference>
<dbReference type="PDB" id="3H1Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.83"/>
<property type="chains" value="P=639-653"/>
</dbReference>
<dbReference type="PDB" id="3H85">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="P=646-653"/>
</dbReference>
<dbReference type="PDBsum" id="2G35"/>
<dbReference type="PDBsum" id="3H1Z"/>
<dbReference type="PDBsum" id="3H85"/>
<dbReference type="ProteinModelPortal" id="O60331"/>
<dbReference type="SMR" id="O60331"/>
<dbReference type="BioGrid" id="116969">
<property type="interactions" value="12"/>
</dbReference>
<dbReference type="DIP" id="DIP-39809N"/>
<dbReference type="IntAct" id="O60331">
<property type="interactions" value="2"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000335333"/>
<dbReference type="BindingDB" id="O60331"/>
<dbReference type="ChEMBL" id="CHEMBL1908383"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2165"/>
<dbReference type="SwissLipids" id="SLP:000000551">
<molecule id="O60331-4"/>
</dbReference>
<dbReference type="iPTMnet" id="O60331"/>
<dbReference type="PhosphoSitePlus" id="O60331"/>
<dbReference type="SwissPalm" id="O60331"/>
<dbReference type="BioMuta" id="PIP5K1C"/>
<dbReference type="EPD" id="O60331"/>
<dbReference type="MaxQB" id="O60331"/>
<dbReference type="PaxDb" id="O60331"/>
<dbReference type="PeptideAtlas" id="O60331"/>
<dbReference type="PRIDE" id="O60331"/>
<dbReference type="DNASU" id="23396"/>
<dbReference type="Ensembl" id="ENST00000335312">
<molecule id="O60331-1"/>
<property type="protein sequence ID" value="ENSP00000335333"/>
<property type="gene ID" value="ENSG00000186111"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000537021">
<molecule id="O60331-2"/>
<property type="protein sequence ID" value="ENSP00000444779"/>
<property type="gene ID" value="ENSG00000186111"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000539785">
<molecule id="O60331-4"/>
<property type="protein sequence ID" value="ENSP00000445992"/>
<property type="gene ID" value="ENSG00000186111"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000589578">
<molecule id="O60331-3"/>
<property type="protein sequence ID" value="ENSP00000466363"/>
<property type="gene ID" value="ENSG00000186111"/>
</dbReference>
<dbReference type="GeneID" id="23396"/>
<dbReference type="KEGG" id="hsa:23396"/>
<dbReference type="UCSC" id="uc002lyj.3">
<molecule id="O60331-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="23396"/>
<dbReference type="DisGeNET" id="23396"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000186111.8"/>
<dbReference type="GeneCards" id="PIP5K1C"/>
<dbReference type="HGNC" id="HGNC:8996">
<property type="gene designation" value="PIP5K1C"/>
</dbReference>
<dbReference type="HPA" id="HPA017168"/>
<dbReference type="MalaCards" id="PIP5K1C"/>
<dbReference type="MIM" id="606102">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="611369">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O60331"/>
<dbReference type="OpenTargets" id="ENSG00000186111"/>
<dbReference type="Orphanet" id="137783">
<property type="disease" value="Lethal congenital contracture syndrome type 3"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33329"/>
<dbReference type="eggNOG" id="KOG0229">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG5253">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00760000119184"/>
<dbReference type="HOGENOM" id="HOG000193876"/>
<dbReference type="HOVERGEN" id="HBG052818"/>
<dbReference type="InParanoid" id="O60331"/>
<dbReference type="KO" id="K00889"/>
<dbReference type="OMA" id="PTDERSW"/>
<dbReference type="OrthoDB" id="EOG091G0A6L"/>
<dbReference type="PhylomeDB" id="O60331"/>
<dbReference type="TreeFam" id="TF319618"/>
<dbReference type="BioCyc" id="MetaCyc:HS02710-MONOMER"/>
<dbReference type="Reactome" id="R-HSA-1660499">
<property type="pathway name" value="Synthesis of PIPs at the plasma membrane"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-399955">
<property type="pathway name" value="SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-6811558">
<property type="pathway name" value="PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8856828">
<property type="pathway name" value="Clathrin-mediated endocytosis"/>
</dbReference>
<dbReference type="SIGNOR" id="O60331"/>
<dbReference type="ChiTaRS" id="PIP5K1C">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="O60331"/>
<dbReference type="GeneWiki" id="PIP5K1C"/>
<dbReference type="GenomeRNAi" id="23396"/>
<dbReference type="PRO" id="PR:O60331"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000186111"/>
<dbReference type="CleanEx" id="HS_PIP5K1C"/>
<dbReference type="Genevisible" id="O60331">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0010008">
<property type="term" value="C:endosome membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005925">
<property type="term" value="C:focal adhesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0001891">
<property type="term" value="C:phagocytic cup"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0098793">
<property type="term" value="C:presynapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0032587">
<property type="term" value="C:ruffle membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0001931">
<property type="term" value="C:uropod"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0052811">
<property type="term" value="F:1-phosphatidylinositol-3-phosphate 4-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0016308">
<property type="term" value="F:1-phosphatidylinositol-4-phosphate 5-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0052812">
<property type="term" value="F:phosphatidylinositol-3,4-bisphosphate 5-kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030036">
<property type="term" value="P:actin cytoskeleton organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034333">
<property type="term" value="P:adherens junction assembly"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0098609">
<property type="term" value="P:cell-cell adhesion"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072583">
<property type="term" value="P:clathrin-dependent endocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061024">
<property type="term" value="P:membrane organization"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030593">
<property type="term" value="P:neutrophil chemotaxis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006909">
<property type="term" value="P:phagocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006661">
<property type="term" value="P:phosphatidylinositol biosynthetic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0014066">
<property type="term" value="P:regulation of phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0048488">
<property type="term" value="P:synaptic vesicle endocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016079">
<property type="term" value="P:synaptic vesicle exocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.800.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.810.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR023610">
<property type="entry name" value="PInositol-4-P-5-kinase"/>
</dbReference>
<dbReference type="InterPro" id="IPR027483">
<property type="entry name" value="PInositol-4-P-5-kinase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR002498">
<property type="entry name" value="PInositol-4-P-5-kinase_core"/>
</dbReference>
<dbReference type="InterPro" id="IPR027484">
<property type="entry name" value="PInositol-4-P-5-kinase_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR23086">
<property type="entry name" value="PTHR23086"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01504">
<property type="entry name" value="PIP5K"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00330">
<property type="entry name" value="PIPKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51455">
<property type="entry name" value="PIPK"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0130">Cell adhesion</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0145">Chemotaxis</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0254">Endocytosis</keyword>
<keyword id="KW-0268">Exocytosis</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0581">Phagocytosis</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0808">Transferase</keyword>
<feature type="chain" description="Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma" id="PRO_0000185462">
<location>
<begin position="1"/>
<end position="668"/>
</location>
</feature>
<feature type="domain" description="PIPK" evidence="5">
<location>
<begin position="75"/>
<end position="443"/>
</location>
</feature>
<feature type="region of interest" description="Mediates interaction with TLN2" evidence="6">
<location>
<begin position="641"/>
<end position="668"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="13">
<location>
<position position="265"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="13">
<location>
<position position="268"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; alternate" evidence="3">
<location>
<position position="459"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine; alternate" evidence="3">
<location>
<position position="459"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="555"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by EGFR" evidence="3">
<location>
<position position="639"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by CSK" evidence="8">
<location>
<position position="649"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK5, MAPK1 and CDK1" evidence="8">
<location>
<position position="650"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3">
<location>
<position position="662"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4">
<location>
<position position="666"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4">
<location>
<position position="668"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_042078" evidence="16">
<original>FPTDERSWVYSPLHYSAQAPPASDGESDT</original>
<variation>FWRLWGPHAPTWPWRREGRAACLCPYPPHVVTPFPGTGLCASWSPDGTGGLGAMSCCVSVS</variation>
<location>
<begin position="640"/>
<end position="668"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042080" evidence="16">
<original>PTDERSWVYSPLHYSAQAPPASDGESDT</original>
<variation>FTDGRYWIYSPRHRRLRAVTLSASGTVSDRSRPPWGEGAVPLGQQGAAGPRPEAQCLTSVVFQKGFG</variation>
<location>
<begin position="641"/>
<end position="668"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_042079" evidence="15">
<location>
<begin position="641"/>
<end position="668"/>
</location>
</feature>
<feature type="sequence variant" description="In LCCS3; loss of activity; dbSNP:rs121908315." id="VAR_036996" evidence="11">
<original>D</original>
<variation>N</variation>
<location>
<position position="253"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to TLN2. Affects localization to focal adhesions." evidence="8">
<original>S</original>
<variation>D</variation>
<location>
<position position="650"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect binding to TLN2 and localization to focal adhesions." evidence="8">
<original>S</original>
<variation>N</variation>
<location>
<position position="650"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 3; BAH14283." ref="3" evidence="17">
<original>V</original>
<variation>M</variation>
<location>
<position position="236"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="644"/>
<end position="646"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3H1Z"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O70161"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5I6B8"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00781"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12422219"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12847086"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15738269"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17261850"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17635937"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17701898"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19548880"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20668706"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25588945"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19548880"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000305"/>
<sequence length="668" mass="73260" checksum="45A9FB32B4E43083" modified="2005-10-25" version="2">
MELEVPDEAESAEAGAVPSEAAWAAESGAAAGLAQKKAAPTEVLSMTAQPGPGHGKKLGH
RGVDASGETTYKKTTSSTLKGAIQLGIGYTVGHLSSKPERDVLMQDFYVVESIFFPSEGS
NLTPAHHFQDFRFKTYAPVAFRYFRELFGIRPDDYLYSLCNEPLIELSNPGASGSLFYVT
SDDEFIIKTVMHKEAEFLQKLLPGYYMNLNQNPRTLLPKFYGLYCVQSGGKNIRVVVMNN
ILPRVVKMHLKFDLKGSTYKRRASKKEKEKSFPTYKDLDFMQDMPEGLLLDADTFSALVK
TLQRDCLVLESFKIMDYSLLLGVHNIDQHERERQAQGAQSTSDEKRPVGQKALYSTAMES
IQGGAARGEAIESDDTMGGIPAVNGRGERLLLHIGIIDILQSYRFIKKLEHTWKALVHDG
DTVSVHRPSFYAERFFKFMSNTVFRKNSSLKSSPSKKGRGGALLAVKPLGPTAAFSASQI
PSEREEAQYDLRGARSYPTLEDEGRPDLLPCTPPSFEEATTASIATTLSSTSLSIPERSP
SETSEQPRYRRRTQSSGQDGRPQEEPPAEEDLQQITVQVEPACSVEIVVPKEEDAGVEAS
PAGASAAVEVETASQASDEEGAPASQASDEEDAPATDIYFPTDERSWVYSPLHYSAQAPP
ASDGESDT
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>